{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:38:21Z","timestamp":1792730301831,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,12]],"date-time":"2027-10-12T00:00:00Z","timestamp":1823299200000},"content-version":"am","delay-in-days":284,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.expneurol.2026.116047","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:14:45Z","timestamp":1791587685000},"page":"116047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Combined pharmacological targeting of NAD+ metabolism preserves central and peripheral axons in an ex vivo model of Wallerian degeneration"],"prefix":"10.1016","volume":"407","author":[{"given":"Thalis","family":"Asimakopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthymia","family":"Kokkinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Faze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Labuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika L.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis E.","family":"Koliatsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios S.","family":"Alexandris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2026.116047_bb0005","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/ars.2023.0350","article-title":"NAD+, axonal maintenance, and neurological disease","volume":"39","author":"Alexandris","year":"2023","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.expneurol.2026.116047_bb0015","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1089\/neu.2022.0416","article-title":"Traumatic axonal injury in the optic nerve: the selective role of SARM1 in the evolution of distal axonopathy","volume":"40","author":"Alexandris","year":"2023","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2026.116047_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105808","article-title":"Protective effects of NAMPT or MAPK inhibitors and NaR on Wallerian degeneration of mammalian axons","volume":"171","author":"Alexandris","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2026.116047_bb0020","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.celrep.2013.04.013","article-title":"The Phr1 ubiquitin ligase promotes injury-induced axon self-destruction","volume":"3","author":"Babetto","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2026.116047_bb0025","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41593-020-0689-4","article-title":"A glycolytic shift in Schwann cells supports injured axons","volume":"23","author":"Babetto","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116047_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-6-6","article-title":"The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves","volume":"6","author":"Beirowski","year":"2005","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.expneurol.2026.116047_bb0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jneumeth.2003.10.016","article-title":"Quantitative and qualitative analysis of Wallerian degeneration using restricted axonal labelling in YFP-H mice","volume":"134","author":"Beirowski","year":"2004","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.expneurol.2026.116047_bb0040","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1093\/brain\/awab184","article-title":"Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy","volume":"144","author":"Bosanac","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2026.116047_bb0050","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1016\/j.neuron.2022.08.017","article-title":"Uncompetitive, adduct-forming SARM1 inhibitors are neuroprotective in preclinical models of nerve injury and disease","volume":"110","author":"Bratkowski","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2026.116047_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107999","article-title":"Structural and mechanistic regulation of the pro-degenerative NAD hydrolase SARM1","volume":"32","author":"Bratkowski","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2026.116047_bb0055","doi-asserted-by":"crossref","first-page":"e3166","DOI":"10.1038\/cddis.2017.489","article-title":"Molecular analysis of axonal-intrinsic and glial-associated co-regulation of axon degeneration","volume":"8","author":"Catenaccio","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.expneurol.2026.116047_bb0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neuroscience.2017.05.022","article-title":"NAMPT inhibitor protects ischemic neuronal injury in rat brain via anti-neuroinflammation","volume":"356","author":"Chen","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2026.116047_bb0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41583-020-0269-3","article-title":"Programmed axon degeneration: from mouse to mechanism to medicine","volume":"21","author":"Coleman","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116047_bb0070","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrn3680","article-title":"Wallerian degeneration: an emerging axon death pathway linking injury and disease","volume":"15","author":"Conforti","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116047_bb0080","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cub.2017.01.070","article-title":"NMN deamidase delays Wallerian degeneration and rescues axonal defects caused by NMNAT2 deficiency in vivo","volume":"27","author":"Di Stefano","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0075","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/cdd.2014.164","article-title":"A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration","volume":"22","author":"Di Stefano","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2026.116047_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-9-66","article-title":"The NAMPT inhibitor FK866 reverts the damage in spinal cord injury","volume":"9","author":"Esposito","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2026.116047_bb0090","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neuron.2017.02.022","article-title":"The SARM1 toll\/Interleukin-1 receptor domain possesses intrinsic NAD+ cleavage activity that promotes pathological axonal degeneration","volume":"93","author":"Essuman","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2026.116047_bb0095","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cub.2017.12.024","article-title":"TIR domain proteins are an ancient family of NAD+-consuming enzymes","volume":"28","author":"Essuman","year":"2018","journal-title":"Curr. Biol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208457119","article-title":"Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain","volume":"119","author":"Feldman","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2026.116047_bb0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0896-6273(00)00084-2","article-title":"Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP","volume":"28","author":"Feng","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2026.116047_bb0110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nbd.2014.05.015","article-title":"DLK-dependent signaling is important for somal but not axonal degeneration of retinal ganglion cells following axonal injury","volume":"69","author":"Fernandes","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2026.116047_bb0115","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.neuron.2021.02.009","article-title":"SARM1 is a metabolic sensor activated by an increased NMN\/NAD+ ratio to trigger axon degeneration","volume":"109","author":"Figley","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2026.116047_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00656","article-title":"Recent advances in NAMPT inhibitors: a novel immunotherapic strategy","volume":"11","author":"Galli","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0125","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1007\/s00018-020-03742-1","article-title":"Enzymology of extracellular NAD metabolism","volume":"78","author":"Gasparrini","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.expneurol.2026.116047_bb0130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1742-2094-8-110","article-title":"Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury","volume":"8","author":"Gaudet","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2026.116047_bb0135","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1083\/jcb.201103153","article-title":"DLK induces developmental neuronal degeneration via selective regulation of proapoptotic JNK activity","volume":"194","author":"Ghosh","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000300","article-title":"Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons","volume":"8","author":"Gilley","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10637-007-9083-2","article-title":"The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor","volume":"26","author":"Holen","year":"2008","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.expneurol.2026.116047_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.703532","article-title":"A novel NAD signaling mechanism in axon degeneration and its relationship to innate immunity","volume":"8","author":"Hopkins","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.expneurol.2026.116047_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108588","article-title":"Small molecule SARM1 inhibitors recapitulate the SARM1\u2212\/\u2212 phenotype and allow recovery of a metastable pool of axons fated to degenerate","volume":"34","author":"Hughes","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2026.116047_bb0160","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/s41586-020-2862-z","article-title":"The NAD+-mediated self-inhibition mechanism of pro-neurodegenerative SARM1","volume":"588","author":"Jiang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2026.116047_bb0165","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1167\/iovs.09-4021","article-title":"In vivo imaging of retinal ganglion cell axons within the nerve fiber layer","volume":"51","author":"Kanamori","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.expneurol.2026.116047_bb0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/acn3.51491","article-title":"A phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS","volume":"9","author":"Katz","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0175","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/WCO.0000000000000763","article-title":"Wallerian degeneration as a therapeutic target in traumatic brain injury","volume":"32","author":"Koliatsos","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0180","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202111053","article-title":"Glial TGF\u03b2 activity promotes neuron survival in peripheral nerves","volume":"222","author":"Lassetter","year":"2023","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/s44386-025-00023-4","article-title":"Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegeneration","volume":"2","author":"Leahey","year":"2025","journal-title":"npj Drug Discov."},{"key":"10.1016\/j.expneurol.2026.116047_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw0064","article-title":"Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening","volume":"11","author":"Lin","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2026.116047_bb0200","doi-asserted-by":"crossref","DOI":"10.1093\/jnen\/nlaf073","article-title":"Temporal progression of axonal degeneration in the visual system in experimental autoimmune encephalomyelitis: insights from high-resolution neuropathology","author":"Liu","year":"2025","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0195","doi-asserted-by":"crossref","first-page":"10654","DOI":"10.1073\/pnas.1809392115","article-title":"Pharmacological bypass of NAD+ salvage pathway protects neurons from chemotherapy-induced degeneration","volume":"115","author":"Liu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2026.116047_bb0205","series-title":"Axon Degeneration, Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-1-0716-0585-1_14","article-title":"Ex vivo analysis of axonal degeneration using sciatic and optic nerve preparations","author":"L\u00f3pez-Leal","year":"2020"},{"key":"10.1016\/j.expneurol.2026.116047_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104678","article-title":"Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration","volume":"134","author":"Loreto","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2026.116047_bb0215","doi-asserted-by":"crossref","DOI":"10.1038\/s44386-025-00016-3","article-title":"SARM1 base-exchange inhibitors induce SARM1 activation and neurodegeneration at low doses","volume":"2","author":"Mani","year":"2025","journal-title":"NPJ Drug Discov."},{"key":"10.1016\/j.expneurol.2026.116047_bb0220","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41580-024-00752-w","article-title":"Regulation of and challenges in targeting NAD+ metabolism","volume":"25","author":"Migaud","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0225","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1634\/theoncologist.2016-0197","article-title":"Sunitinib: ten years of successful clinical use and study in advanced renal cell carcinoma","volume":"22","author":"Motzer","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.expneurol.2026.116047_bb0230","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.neuro.30.051606.094309","article-title":"Axon-glial signaling and the glial support of axon function","volume":"31","author":"Nave","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116047_bb0235","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1523\/JNEUROSCI.5204-08.2009","article-title":"Axonal protective effects of the myelin-associated glycoprotein","volume":"29","author":"Nguyen","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116047_bb0240","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt.4281","article-title":"Protection of tissue physicochemical properties using polyfunctional crosslinkers","volume":"37","author":"Park","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0245","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1084\/jem.165.4.1218","article-title":"The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration","volume":"165","author":"Perry","year":"1987","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2026.116047_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13103","article-title":"NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells","volume":"7","author":"Ratajczak","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2026.116047_bb0255","series-title":"Base Exchange Inhibitors of SARM1 form Mononucleotide Adducts and Activate SARM1 in Vivo","author":"Reardon","year":"2025"},{"key":"10.1016\/j.expneurol.2026.116047_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113252","article-title":"cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons","volume":"329","author":"Sasaki","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0265","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1523\/JNEUROSCI.3304-17.2018","article-title":"Dysregulation of NAD+ metabolism induces a Schwann cell dedifferentiation program","volume":"38","author":"Sasaki","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116047_bb0260","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.19749","article-title":"NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD+ depletion","volume":"5","author":"Sasaki","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.expneurol.2026.116047_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113842","article-title":"Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection","volume":"345","author":"Sasaki","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0280","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad067","article-title":"Uman-type neurofilament light antibodies are effective reagents for the imaging of neurodegeneration","volume":"5","author":"Shaw","year":"2023","journal-title":"Brain Commun."},{"key":"10.1016\/j.expneurol.2026.116047_bb0285","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neuron.2012.04.028","article-title":"Dual leucine zipper kinase is required for retrograde injury signaling and axonal regeneration","volume":"74","author":"Shin","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2026.116047_bb0290","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.nbd.2019.02.001","article-title":"DLK regulates a distinctive transcriptional regeneration program after peripheral nerve injury","volume":"127","author":"Shin","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2026.116047_bb0295","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.cmet.2025.04.007","article-title":"Nicotinic acid riboside maintains NAD+ homeostasis and ameliorates aging-associated NAD+ decline","volume":"37","author":"Song","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.expneurol.2026.116047_bb0300","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62021","article-title":"Structural basis for SARM1 inhibition and activation under energetic stress","volume":"9","author":"Sporny","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.expneurol.2026.116047_bb0305","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/BF01187086","article-title":"Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation","volume":"18","author":"Stoll","year":"1989","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0315","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s12035-019-01796-2","article-title":"DLK activation synergizes with mitochondrial dysfunction to downregulate axon survival factors and promote SARM1-dependent axon degeneration","volume":"57","author":"Summers","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0310","doi-asserted-by":"crossref","first-page":"E8746","DOI":"10.1073\/pnas.1806933115","article-title":"Palmitoylation enables MAPK-dependent proteostasis of axon survival factors","volume":"115","author":"Summers","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2026.116047_bb0320","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.1128\/JVI.00836-09","article-title":"The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile Virus pathogenesis","volume":"83","author":"Szretter","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0325","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/acn3.51044","article-title":"Neuroprotective effects of FK866 against traumatic brain injury: involvement of p38\/ERK pathway","volume":"7","author":"Tan","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0330","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/embor.2013.64","article-title":"The DLK signalling pathway\u2014a double-edged sword in neural development and regeneration","volume":"14","author":"Tedeschi","year":"2013","journal-title":"EMBO Rep."},{"key":"10.1016\/j.expneurol.2026.116047_bb0335","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2015.02.014","article-title":"Cytoskeletal disruption activates the DLK\/JNK pathway, which promotes axonal regeneration and mimics a preconditioning injury","volume":"77","author":"Valakh","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2026.116047_bb0340","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22540","article-title":"MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2","volume":"6","author":"Walker","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.expneurol.2026.116047_bb0345","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1098\/rstl.1850.0021","article-title":"Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibres","volume":"140","author":"Waller","year":"1850","journal-title":"Philos. Trans. R. Soc."},{"key":"10.1016\/j.expneurol.2026.116047_bb0350","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1073\/pnas.1211074110","article-title":"DLK initiates a transcriptional program that couples apoptotic and regenerative responses to axonal injury","volume":"110","author":"Watkins","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2026.116047_bb0360","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.neuron.2017.06.008","article-title":"Enhanced functional genomic screening identifies novel mediators of dual leucine zipper kinase-dependent injury signaling in neurons","volume":"94","author":"Welsbie","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2026.116047_bb0355","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1073\/pnas.1211284110","article-title":"Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death","volume":"110","author":"Welsbie","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2026.116047_bb0365","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13024-019-0345-1","article-title":"Targeted disruption of dual leucine zipper kinase and leucine zipper kinase promotes neuronal survival in a model of diffuse traumatic brain injury","volume":"14","author":"Welsbie","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2026.116047_bb0370","article-title":"Liposome-based loading enhances the distribution of nicotinamide riboside chloride into the brain and its neuroprotective effects in cerebral ischemic mice","volume":"12","author":"Xie","year":"2024","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001440","article-title":"The Highwire ubiquitin ligase promotes axonal degeneration by tuning levels of Nmnat protein","volume":"10","author":"Xiong","year":"2012","journal-title":"PLoS Biol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0380","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cell.2014.11.053","article-title":"Pathological axonal death through a MAPK cascade that triggers a local energy deficit","volume":"160","author":"Yang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2026.116047_bb0395","article-title":"SARM1 activation promotes axonal degeneration via a two-step phase transition","author":"Zhang","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.expneurol.2026.116047_bb0390","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1038\/s41467-025-58036-6","article-title":"Inhibiting acute, axonal DLK palmitoylation is neuroprotective and avoids deleterious effects of cell-wide DLK inhibition","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2026.116047_bb0385","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neuroscience.2015.02.007","article-title":"NAMPT inhibitor and metabolite protect mouse brain from cryoinjury through distinct mechanisms","volume":"291","author":"Zhang","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2026.116047_bb0400","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.isci.2019.05.001","article-title":"A cell-permeant mimetic of NMN activates SARM1 to produce cyclic ADP-ribose and induce non-apoptotic cell death","volume":"15","author":"Zhao","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.expneurol.2026.116047_bb0405","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1523\/JNEUROSCI.2343-17.2018","article-title":"Primary traumatic axonopathy in mice subjected to impact acceleration: a reappraisal of pathology and mechanisms with high-resolution anatomical methods","volume":"38","author":"Ziogas","year":"2018","journal-title":"J. Neurosci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626004140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626004140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:05:01Z","timestamp":1792728301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488626004140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":81,"alternative-id":["S0014488626004140"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.116047","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined pharmacological targeting of NAD+ metabolism preserves central and peripheral axons in an ex vivo model of Wallerian degeneration","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.116047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116047"}}